Huafeng Wang

Huafeng Wang has a diverse background in biomedical research, holding roles such as Principal Scientist at Shoreline Biosciences, Inc., Senior Scientist at Regulus Therapeutics, and Postdoc Fellow at California Institute for Biomedical Research (Calibr). Their experience includes leading high-throughput drug screening projects, vaccine development, and research in immunology. Prior to this, they served as a Postdoctoral Research Associate at the University of Wisconsin-Madison and as an Assistant Researcher at the Shanghai Institutes for Biological Sciences, where they focused on virulence factors, mouse models, and received awards for their contributions.

Huafeng Wang pursued a Doctor of Philosophy (PhD) in Biochemistry and Molecular Biology from 2003 to 2008 at the Shanghai Institutes for Biological Sciences.